Hannelore Rösch

Title: Hannelore Rösch: Innovator in Oligoribonucleotide Research

Introduction

Hannelore Rösch is a distinguished inventor based in Erbach, Germany. She has made significant contributions to the field of molecular biology, particularly in the development of oligoribonucleotide analogs. Her innovative work has led to advancements that enhance the stability and functionality of these molecules.

Latest Patents

Hannelore Rösch holds a patent for her invention titled "Oligoribonucleotide and ribozyme analogs with terminal 3′—3′ and/or 5′—5′ linkages." This invention relates to oligoribonucleotide analogs that feature terminal 3′—3′ and/or 5′—5′ internucleotide linkages. The modifications introduced by her research stabilize the molecules, including ribozymes, without adversely affecting their properties, including catalytic activities.

Career Highlights

Hannelore Rösch is associated with Aventis Pharma Deutschland GmbH, where she has been able to apply her expertise in the pharmaceutical industry. Her work has been pivotal in advancing the understanding and application of ribozymes and oligoribonucleotides in various therapeutic contexts.

Collaborations

Throughout her career, Hannelore has collaborated with notable colleagues, including Heinz Hartmut Seliger and Flavio Ramalho Ortigao. These collaborations have further enriched her research and contributed to the success of her innovations.

Conclusion

Hannelore Rösch's contributions to the field of oligoribonucleotide research exemplify her dedication to innovation and scientific advancement. Her patent and work at Aventis Pharma highlight her role as a key figure in molecular biology.